Figure 5 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

Read full text
Authors: Esther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín‐Aguilera, Sandra Cobo, Blanca González‐Farré, Eva Hernández‐Illán, Pedro Jares, Joan Anton Puig‐Butille, Montserrat Muñoz-Mateu, Raquel Gómez-Bravo, Marta Tapia, Cristina Tebar
+17 more Cristina Saura, Santiago Escrivá-de-Romaní, Jesús Soberino, Javier Cortés, Serafin M. Morales, Kepa Amillano, Laia Paré, Patricia Villagrasa, Wesley Buckingham, Francisco Pardo, Joel S. Parker, Fara Brasó‐Maristany, Eva Ciruelos, Rodrigo Sánchez-Bayona, Olga Martínez‐Sáez, Juan Miguel Cejalvo, Aleix Prat
Cited by: 0

Abstract

Correlations between HER2DX molecular modules and pathology features. Heatmap of Pearson correlation coefficients between HER2DX scores/modules (pCR score, risk score, ERBB2 score, IGG, proliferation, and luminal) and pathologic features (TIL%, Ki67, HR status, TLS, HER2 IHC, tumor grade, and spatial pattern; A); scatter plots showing IGG score vs. TIL% (B), proliferation score vs. Ki67% (C), luminal score vs. binary HR status (D), and luminal score vs. ER % levels (E). Correlation values and P values are shown; positive correlations reflect biological concordance between genomic and pathologic features. Statistical comparisons were performed using appropriate parametric tests.

Fields of Study & Subjects

HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Cancer Genomics and Diagnostics

Publication details

Publication date
4 February 2026